Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 48,768 | 44,130 | 34,046 | 32,644 | 20,596 |
| Cost of Goods | 5,596 | 5,367 | 4,055 | 4,344 | 4,310 |
| Gross Profit | 43,172 | 38,763 | 29,991 | 28,300 | 16,286 |
| Operating Expenses | 101,073 | 115,560 | 111,325 | 98,127 | 172,777 |
| Operating Income | -57,305 | -76,430 | -81,279 | -69,483 | -156,181 |
| Interest Expense | 4,026 | 4,625 | 6,454 | 8,639 | 4,715 |
| Other Income | -729 | -2,779 | -32,398 | 1,049 | 1,682 |
| Pre-tax Income | -62,060 | -83,834 | -120,131 | -77,073 | -159,214 |
| Income Tax | -251 | 717 | 168 | 1,010 | -51 |
| Net Income Continuous | -61,809 | -84,551 | -120,299 | -78,083 | -159,163 |
| Net Income | $-61,809 | $-84,551 | $-120,299 | $-78,083 | $-159,163 |
| EPS Basic Total Ops | -0.24 | -0.36 | -0.56 | -0.43 | -0.84 |
| EPS Basic Continuous Ops | -0.24 | -0.36 | -0.56 | -0.43 | -0.84 |
| EPS Diluted Total Ops | -0.24 | -0.36 | -0.56 | -0.43 | -0.84 |
| EPS Diluted Continuous Ops | -0.24 | -0.36 | -0.56 | -0.43 | -0.84 |
| EBITDA(a) | $-56,003 | $-74,821 | $-78,639 | $-65,174 | $-152,513 |